Cite
Ellagic acid protects against non-alcoholic fatty liver disease in streptozotocindiabetic rats by activating AMPK.
MLA
AL Tamimi, Jozaa Z., et al. “Ellagic Acid Protects against Non-Alcoholic Fatty Liver Disease in Streptozotocindiabetic Rats by Activating AMPK.” Pharmaceutical Biology, vol. 60, no. 1, Dec. 2022, pp. 25–37. EBSCOhost, https://doi.org/10.1080/13880209.2021.1990969.
APA
AL Tamimi, J. Z., Alshammari, G. M., AlFaris, N. A., Alagal, R. I., Aljabryn, D. H., Albekairi, N. A., Alkhateeb, M. A., & Yahya, M. A. (2022). Ellagic acid protects against non-alcoholic fatty liver disease in streptozotocindiabetic rats by activating AMPK. Pharmaceutical Biology, 60(1), 25–37. https://doi.org/10.1080/13880209.2021.1990969
Chicago
AL Tamimi, Jozaa Z., Ghedeir M. Alshammari, Nora A. AlFaris, Reham I. Alagal, Dalal H. Aljabryn, Norah A. Albekairi, Mahmoud Ahmad Alkhateeb, and Mohammed Abdo Yahya. 2022. “Ellagic Acid Protects against Non-Alcoholic Fatty Liver Disease in Streptozotocindiabetic Rats by Activating AMPK.” Pharmaceutical Biology 60 (1): 25–37. doi:10.1080/13880209.2021.1990969.